CNBC Fast Money
2026-08-03 · Hosted by Melissa Lee · CNBC
Executive Summary
Treasury yields kept climbing Friday — the 10-year near a level not seen since January 2025 and the 30-year closing in on 5.3%, its first time near that mark in 19 years — after two Fed dissenters, Cleveland's Beth Hammack and Minneapolis's Neel Kashkari, argued for a rate hike. Stocks still closed the week higher, with the panel viewing resilient equities alongside rising yields as a healthy sign of a broadening market. Amazon had its best day in 14 years on 37% AWS growth, while Apple dropped 7%, losing over $400 billion in market cap, on supply-constraint warnings.
Key Stories & Changes
1. Treasury Yields Climb on Fed Dissent and Hawkish Signals
The 10-year yield hit its highest level since January 2025; the 30-year approached 5.3%, a level not seen in 19 years.
Fed dissenters Beth Hammack (Cleveland) and Neel Kashkari (Minneapolis) argued small hikes now could preclude larger hikes later.
Panelist Tim Seymour: break-evens (market-implied inflation expectations) have stayed static since the Fed meeting, suggesting the yield move reflects positioning and Fed-credibility questions rather than a genuine inflation scare.
Rick Santelli flagged 5% on the 10-year as "in sight."
2. Amazon and Apple: Diverging Earnings Reactions
Amazon had its best day in 14 years, with AWS growing 37% year-over-year, the fastest pace in 18 quarters, and its chip-rental business reaching a $25 billion run rate.
Apple dropped 7%, losing over $400 billion in market cap, after warning supply constraints will weigh on current-quarter revenue; shares are down 10% since a record high set just Tuesday.
Panelist Courtney: Apple was "priced to fail" given elevated expectations; the memory chip cost pass-through to consumers in the next iPhone cycle is the key variable to watch.
Panelist Bonawyn: Amazon's differentiator was "visibility of revenue and backlog attached to that CapEx spend," unlike peers criticized for spending without proof of monetization.
AMZN: Amazon — Best day in 14 years — AWS growth of 37% blew past 31-34% Street estimates
AAPL: Apple — -7% — Supply constraints to weigh on current-quarter revenue
NVO: Novo Nordisk — -8% to -9% — Cardiovascular drug failed to reduce major adverse events vs. placebo
XOM: Exxon Mobil — Underperformed Chevron by ~3.5% — Weak refining segment; free cash flow beat by 20%+ ($19.2B)
CVX: Chevron — Outperformed Exxon — Beat both top and bottom line
RBLX: Roblox — -27% — Missed bookings and daily active users
RDDT: Reddit — -21% — Worst day on record on Google search traffic warning
PLTR: Palantir — Reports Monday — Revenue up 85% last quarter, net dollar retention 150%, but 77x forward P/E
3. Fed Communication Style Debate Intensifies
Panelists debated whether Chair Worsh's less-transparent approach (vs. Powell's forward guidance) is deliberate strategy or a source of instability.
New York Times report: Worsh is considering cutting FOMC meetings from eight to four per year — the legal minimum.
Historical note cited: the Fed hasn't gone longer than eight weeks between meetings since 1981 under Paul Volcker.
Panelist Tim Seymour: "the six-month chart on the 10-year" argues for continued higher rates; "nothing about that chart... says rates aren't going higher."
4. Software Surges as Semiconductors Diverge
Software index (IGV) rose six days in a row, its best week in two months; Microsoft up 22% since Monday, adding $560 billion in market value — its best week since 1999.
Workday, Oracle, and Salesforce also posted double-digit gains.
Software gained ~7% on the week while semiconductors fell almost 4%, driven partly by unwinding of long/short positioning tied to memory-name volatility.
Cybersecurity names (CrowdStrike, Palo Alto) cited as beneficiaries of the AI "going rogue" headlines, drawing more investor focus to the security software subsector.
5. Oil Majors: Chevron Beats, Exxon Misses on Refining
Chevron beat both top and bottom line; Exxon missed on refining margin volatility tied to crude supply disruption, per CEO Darren Woods.
Both stocks up ~29% year-to-date; panelists noted the charts "look identical" despite the earnings-day divergence.
Exxon's larger free cash flow beat (~$19.2 billion, +20% vs. expectations) was seen as underappreciated amid the refining-driven selloff.
6. Novo Nordisk's Pipeline Setback
Novo Nordisk shares fell roughly 8-9% after its cardiovascular drug failed to show a meaningful reduction in major adverse cardiovascular events versus placebo in a late-stage trial.
Guest Jared Holz (Mizuho) sized the lost opportunity at $5-10 billion, calling the stock reaction "roughly" proportionate.
Holz noted this increases pressure on Novo to pursue M&A to diversify beyond its obesity/diabetes franchise.
Trends Identified
1. The AI Trade Is Bifurcating Between Monetizers and Spenders Without Proof
Across Amazon, Microsoft, and the broader AI food chain, panelists repeatedly distinguished between companies showing visible ROI (Amazon, Microsoft) and those still asking investors to trust the spend (implicitly, Meta and others). This bifurcation is increasingly the dominant lens for evaluating hyperscaler earnings reactions.
2. Fed Communication Uncertainty Is Becoming a Standalone Market Risk
The debate over Chair Worsh's opacity — and the prospect of halving FOMC meeting frequency — suggests investors are pricing in a structurally less predictable Fed, which panelists linked directly to this week's yield volatility, independent of the underlying inflation data.
3. Software/Semiconductor Rotation Reflects a Broader "De-Risking" of Momentum Trades
The sharp divergence between surging software and falling semiconductors this week continues a theme of unwinding crowded, leveraged momentum positions (evident also in the SpaceX and hedge-fund-unwind context), rather than a fundamental reassessment of AI demand.
4. Biotech Binary Events Continue to Dominate Pharma Sentiment
Novo Nordisk's trial failure, following a string of earlier setbacks, reinforces a "de-risked" (lower-expectation, already-discounted) valuation thesis among bulls like Bonawyn, even as near-term momentum remains negative. ---
Sentiment Analysis
Overall Market Sentiment: Resilient but Vigilant
Panelists broadly framed the week's equity strength alongside rising yields as healthy broadening, while flagging Fed communication risk and stretched valuations in pockets like Palantir and AI infrastructure names.
Risk Factors Highlighted
Rising Treasury yields approaching 5% on the 10-year: Flagged repeatedly as a headwind for equity valuations, particularly long-duration growth names.
Fed communication uncertainty and possible reduced meeting cadence: Could produce more volatile, unpredictable policy moves.
Stretched valuations in AI-adjacent momentum names: Palantir's 77x forward P/E and semiconductor volatility cited as vulnerable to further unwinds.
Financing risk for continued hyperscaler CapEx: Panelists note negative free cash flow at some hyperscalers increases reliance on debt/equity markets amid rising rates.
Market complacency: Guest Megan Horniman explicitly warns of downside risk from tariffs, Fed policy, and seasonal weakness heading into August.
SpaceX lock-up expiration and earnings volatility: Options market pricing a 16.5% implied move around next week's first public earnings report.
Biotech trial-outcome risk: Novo Nordisk's failed cardiovascular trial underscores binary downside risk in pharma pipelines.
AI cybersecurity incidents: Referenced in context of software-sector rotation toward security names, reflecting ongoing concern about AI models "going rogue."
This episode was covered in today's [The Market Signal — 2026-08-03](https://marketsignal.beehiiv.com/p/the-market-signal-2026-08-03), a cross-source synthesis of multiple podcast reports.